Last reviewed · How we verify
albuterol/salbutamol HFA
albuterol/salbutamol HFA is a Beta-2 adrenergic receptor agonist Small molecule drug developed by Teva Branded Pharmaceutical Products R&D, Inc.. It is currently in Phase 3 development for Maintenance and relief of bronchospasm in asthma and chronic obstructive pulmonary disease (COPD), Prevention of bronchospasm during exercise. Also known as: ProAir HFA, short-acting β2-adrenergic agonists.
Albuterol/salbutamol HFA is a short-acting beta-2 adrenergic receptor agonist that works by relaxing bronchial muscles to improve airflow to the lungs.
Albuterol/salbutamol HFA is a short-acting beta-2 adrenergic receptor agonist that works by relaxing bronchial muscles to improve airflow to the lungs. Used for Maintenance and relief of bronchospasm in asthma and chronic obstructive pulmonary disease (COPD), Prevention of bronchospasm during exercise.
At a glance
| Generic name | albuterol/salbutamol HFA |
|---|---|
| Also known as | ProAir HFA, short-acting β2-adrenergic agonists |
| Sponsor | Teva Branded Pharmaceutical Products R&D, Inc. |
| Drug class | Beta-2 adrenergic receptor agonist |
| Target | Beta-2 adrenergic receptor |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | Phase 3 |
Mechanism of action
This medication is a bronchodilator that helps to open up the airways in the lungs, making it easier to breathe. It works by stimulating the beta-2 receptors in the bronchial muscles, causing them to relax and dilate. This results in improved airflow and reduced symptoms of asthma and COPD.
Approved indications
- Maintenance and relief of bronchospasm in asthma and chronic obstructive pulmonary disease (COPD)
- Prevention of bronchospasm during exercise
Common side effects
- Tremors
- Nervousness
- Headache
- Dizziness
- Palpitations
Key clinical trials
- Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. (PHASE3)
- Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma (NA)
- Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma (PHASE4)
- A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma (PHASE3)
- Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- Advair HFA in Healthy and HAPE Predisposed Subjects (PHASE1, PHASE2)
- Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype (EARLY_PHASE1)
- BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- albuterol/salbutamol HFA CI brief — competitive landscape report
- albuterol/salbutamol HFA updates RSS · CI watch RSS
- Teva Branded Pharmaceutical Products R&D, Inc. portfolio CI
Frequently asked questions about albuterol/salbutamol HFA
What is albuterol/salbutamol HFA?
How does albuterol/salbutamol HFA work?
What is albuterol/salbutamol HFA used for?
Who makes albuterol/salbutamol HFA?
Is albuterol/salbutamol HFA also known as anything else?
What drug class is albuterol/salbutamol HFA in?
What development phase is albuterol/salbutamol HFA in?
What are the side effects of albuterol/salbutamol HFA?
What does albuterol/salbutamol HFA target?
Related
- Drug class: All Beta-2 adrenergic receptor agonist drugs
- Target: All drugs targeting Beta-2 adrenergic receptor
- Manufacturer: Teva Branded Pharmaceutical Products R&D, Inc. — full pipeline
- Therapeutic area: All drugs in Respiratory
- Indication: Drugs for Maintenance and relief of bronchospasm in asthma and chronic obstructive pulmonary disease (COPD)
- Indication: Drugs for Prevention of bronchospasm during exercise
- Also known as: ProAir HFA, short-acting β2-adrenergic agonists
- Compare: albuterol/salbutamol HFA vs similar drugs
- Pricing: albuterol/salbutamol HFA cost, discount & access